Not only have we had discussions with the Canadian government, but the Canadian government sits on our board. We are always discussing it with the board member and others, including through our governance.
We have basically discussed in depth the strategy of the Global Fund. The strategy was designed and approved by our board. The strategy says we stick to our 2030 targets and to our commitments—to our mandate, if you wish—to end AIDS, TB and malaria by 2030. Based on that, we've calculated the funding needs over the next three years in order to be back on track to reach those targets. Those calculations were made by technical partners, not by us, based on their global plans.
That gives us the $18 billion target for the Global Fund, which represents a 30% increase. This was discussed with the Canadian board member and the Canadian government as the basic requirement in order to get back on track.
To give you an idea, that $18 billion still leaves $28 billion unfunded in the global plans to end HIV, TB and malaria by 2030. It's not a very ambitious target. It leaves a lot of funding needs still unmet if we are to meet the 2030 targets.
Yes, we have discussed that, but we have, obviously, not come to a conclusion when it comes to the Canadian commitment.